Maag Peter
Director at CDNA
- Sold, on record
- $46.8M
- Dollars the filings state
- Form 4 sales
- 55
- Latest Jul 7, 2025
- Form 144 notices
- 5
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- CDNACareDx, Inc.Director
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice CDNANoticeAug 20, 2024 2024
Filed to sell 35,552 shares ($1.2M)
Maag Peter, Director
No 10b5-1 plan8.6x usual sizeFiling
- 2 Form 4 sale CDNAUnusualAug 20, 2024 same day
Sold 35,552 shares at $33.04 ($1.2M)
Maag Peter, Director
No 10b5-1 planSold 9.7% of holdings ($12.1M position)330,024 shares left8.6x usual sizeFollows a Form 144Filing
- 3 Form 144 notice CDNANoticeNov 26, 2024 +98 days
Filed to sell 5,000 shares ($121k)
Maag Peter, Director
10b5-1 planFirst sale on recordFiling
- 4 Form 4 sale CDNARoutineNov 26, 2024 same day
Sold 5,000 shares at $25.00 ($125k)
Maag Peter, Director
10b5-1 planSold 1.5% of holdings ($8.4M position)330,024 shares leftFirst sale on recordFollows a Form 144Filing
- 5 Form 144 notice CDNANoticeApr 30, 2025 +155 days
Filed to sell 33,281 shares ($603k)
Maag Peter, Director
10b5-1 plan6.7x usual sizeFiling
- 6 Form 4 sale CDNARoutineApr 30, 2025 same day
Sold 13,281 shares at $17.23 ($229k)
Maag Peter, Director
10b5-1 planSold 4% of holdings ($5.7M position)316,743 shares left2.7x usual sizeFollows a Form 144Filing
- 7 Form 4 sale CDNARoutineJun 17, 2025 +48 days
Sold 10,000 shares at $19.24 ($192k)
Maag Peter, Director
10b5-1 planSold 3% of holdings ($6.3M position)318,846 shares left2x usual sizeFiling
- 8 Form 4 sale CDNANo planJul 7, 2025 +20 days
Sold 10,000 shares at $18.58 ($186k)
Maag Peter, Director
No 10b5-1 planSold 3.1% of holdings ($5.9M position)308,846 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (60)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jul 7, 2025 | Jul 10, 2025 | CDNA | Director | Form 4 sale | 10,000 | $186k | 3.1% | No plan | SEC |
| Jun 17, 2025 | Jun 20, 2025 | CDNA | Director | Form 4 sale | 10,000 | $192k | 3.0% | Routine | SEC |
| Apr 30, 2025 | May 2, 2025 | CDNA | Director | Form 4 sale | 13,281 | $229k | 4.0% | Routine | SEC |
| Apr 30, 2025 | Apr 30, 2025 | CDNA | Director | Form 144 notice | 33,281 | $603k | Notice | SEC | |
| Nov 26, 2024 | Dec 3, 2024 | CDNA | Director | Form 4 sale | 5,000 | $125k | 1.5% | Routine | SEC |
| Nov 26, 2024 | Nov 26, 2024 | CDNA | Director | Form 144 notice | 5,000 | $121k | Notice | SEC | |
| Aug 20, 2024 | Aug 22, 2024 | CDNA | Director | Form 4 sale | 35,552 | $1.2M | 9.7% | Unusual | SEC |
| Aug 20, 2024 | Aug 20, 2024 | CDNA | Director | Form 144 notice | 35,552 | $1.2M | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | CDNA | Director | Form 144 notice | 5,000 | $52k | Notice | SEC | |
| Jul 13, 2023 | Jul 13, 2023 | CDNA | Director | Form 4 sale | 5,000 | $52k | 1.6% | No plan | SEC |
| Jun 28, 2023 | Jun 28, 2023 | CDNA | Director | Form 144 notice | 2,432 | $21k | Notice | SEC | |
| Jun 28, 2023 | Jun 28, 2023 | CDNA | Director | Form 4 sale | 2,432 | $21k | 0.8% | No plan | SEC |
| Feb 8, 2023 | Feb 8, 2023 | CDNA | Director | Form 4 sale | 3,269 | $51k | 1.1% | Plan not stated | SEC |
| Feb 2, 2023 | Feb 3, 2023 | CDNA | Director | Form 4 sale | 5,000 | $86k | 1.6% | Plan not stated | SEC |
| Aug 11, 2022 | Aug 11, 2022 | CDNA | Director | Form 4 sale | 20,000 | $493k | 6.3% | Plan not stated | SEC |
| Apr 5, 2022 | Apr 6, 2022 | CDNA | Director | Form 4 sale | 10,000 | $386k | 3.1% | Plan not stated | SEC |
| Mar 7, 2022 | Mar 8, 2022 | CDNA | Director | Form 4 sale | 10,000 | $328k | 3.1% | Plan not stated | SEC |
| Feb 7, 2022 | Feb 8, 2022 | CDNA | Director | Form 4 sale | 10,000 | $421k | 3.1% | Plan not stated | SEC |
| Jan 5, 2022 | Jan 6, 2022 | CDNA | Director | Form 4 sale | 10,000 | $444k | 2.8% | Plan not stated | SEC |
| Dec 6, 2021 | Dec 7, 2021 | CDNA | Director | Form 4 sale | 10,000 | $416k | 2.8% | Plan not stated | SEC |
| Nov 5, 2021 | Nov 9, 2021 | CDNA | Director | Form 4 sale | 10,000 | $494k | 2.8% | Plan not stated | SEC |
| Oct 5, 2021 | Oct 6, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $647k | 2.8% | Plan not stated | SEC |
| Sep 7, 2021 | Sep 7, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $737k | 2.8% | Plan not stated | SEC |
| Aug 5, 2021 | Aug 9, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $831k | 2.8% | Plan not stated | SEC |
| Jul 6, 2021 | Jul 7, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $907k | 2.7% | Plan not stated | SEC |
| Jun 25, 2021 | Jun 25, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $953k | 2.6% | Plan not stated | SEC |
| Jun 9, 2021 | Jun 11, 2021 | CDNA | Executive Chair | Form 4 sale | 2,522 | $227k | 0.7% | Plan not stated | SEC |
| Jun 8, 2021 | Jun 9, 2021 | CDNA | Executive Chair | Form 4 sale | 978 | $88k | 0.3% | Plan not stated | SEC |
| Jun 7, 2021 | Jun 8, 2021 | CDNA | Executive Chair | Form 4 sale | 26,500 | $2.3M | 6.7% | Plan not stated | SEC |
| May 25, 2021 | May 27, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $806k | 2.4% | Plan not stated | SEC |
| May 11, 2021 | May 12, 2021 | CDNA | Executive Chair | Form 4 sale | 113,421 | $7.6M | 21.7% | Unusual | SEC |
| May 5, 2021 | May 6, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $733k | 2.4% | Plan not stated | SEC |
| May 3, 2021 | May 4, 2021 | CDNA | Executive Chair | Form 4 sale | 20,000 | $1.5M | 4.7% | Plan not stated | SEC |
| Apr 5, 2021 | Apr 6, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $724k | 2.4% | Plan not stated | SEC |
| Mar 5, 2021 | Mar 5, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $613k | 2.3% | Plan not stated | SEC |
| Feb 5, 2021 | Feb 5, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $898k | 2.4% | Plan not stated | SEC |
| Jan 5, 2021 | Jan 6, 2021 | CDNA | Executive Chair | Form 4 sale | 10,000 | $719k | 2.3% | Plan not stated | SEC |
| Dec 7, 2020 | Dec 8, 2020 | CDNA | Executive Chair | Form 4 sale | 10,000 | $664k | 2.3% | Plan not stated | SEC |
| Nov 5, 2020 | Nov 5, 2020 | CDNA | Executive Chair | Form 4 sale | 10,000 | $535k | 2.3% | Plan not stated | SEC |
| Oct 5, 2020 | Oct 6, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 10,000 | $421k | 2.3% | Plan not stated | SEC |
| Oct 1, 2020 | Oct 2, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 20,000 | $810k | 4.5% | Plan not stated | SEC |
| Sep 30, 2020 | Sep 30, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 16,992 | $639k | 3.9% | Plan not stated | SEC |
| Sep 8, 2020 | Sep 8, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 9,900 | $314k | 2.3% | Plan not stated | SEC |
| Aug 5, 2020 | Aug 7, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 13,008 | $478k | 3.0% | Plan not stated | SEC |
| Jul 6, 2020 | Jul 7, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 10,000 | $342k | 2.3% | Plan not stated | SEC |
| Jun 30, 2020 | Jul 2, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 18,182 | $638k | 4.5% | Plan not stated | SEC |
| Jun 9, 2020 | Jun 11, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 1,818 | $64k | 0.5% | Plan not stated | SEC |
| Jun 5, 2020 | Jun 5, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 50,000 | $1.6M | 11.3% | Plan not stated | SEC |
| May 19, 2020 | May 19, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 30,000 | $967k | 6.1% | Plan not stated | SEC |
| Mar 16, 2020 | Mar 16, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 10,000 | $174k | 2.0% | Plan not stated | SEC |
| Feb 18, 2020 | Feb 19, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 10,000 | $266k | 2.2% | Plan not stated | SEC |
| Jan 15, 2020 | Jan 16, 2020 | CDNA | Chief Executive Officer | Form 4 sale | 10,000 | $231k | 2.3% | Plan not stated | SEC |
| Aug 6, 2019 | Aug 8, 2019 | CDNA | Chief Executive Officer | Form 4 sale | 50,000 | $1.4M | 12.8% | Plan not stated | SEC |
| May 13, 2019 | May 13, 2019 | CDNA | Chief Executive Officer | Form 4 sale | 80,000 | $2.5M | 16.4% | Plan not stated | SEC |
| Apr 12, 2019 | Apr 12, 2019 | CDNA | Officer, Director | Form 4 sale | 100,000 | $2.9M | 18.6% | Plan not stated | SEC |
| Mar 11, 2019 | Mar 11, 2019 | CDNA | Officer, Director | Form 4 sale | 50,000 | $1.7M | 9.8% | Plan not stated | SEC |
| Nov 29, 2018 | Nov 30, 2018 | CDNA | Officer, Director | Form 4 sale | 100,000 | $2.9M | 20.0% | Unusual | SEC |
| Nov 13, 2018 | Nov 15, 2018 | CDNA | Officer, Director | Form 4 sale | 50,000 | $1.3M | 11.4% | Plan not stated | SEC |
| Sep 4, 2018 | Sep 4, 2018 | CDNA | Officer, Director | Form 4 sale | 15,000 | $347k | 3.3% | Plan not stated | SEC |
| Mar 27, 2018 | Mar 28, 2018 | CDNA | Officer, Director | Form 4 sale | 15,000 | $118k | 5.2% | Plan not stated | SEC |